Here are seven key facts from that procedure:
1. Dr. Buch has performed seven previous knee and humorous surgeries using implants from Implantcast.
2. Implantcast is a product company based out of Europe that has not yet been approved by the U.S. Food and Drug Administration for widespread use in the United States. This means that each U.S. case must be first approved by the FDA.
3. Dr. Buch specializes in Orthopedic Revisions and Orthopedic Oncology and is the first and only surgeon who has been approved to use any of Implantcast’s implants in the United States.
4. Due to a severe infection in the elbow, the patient had to have an entire distal replacement performed.
5. MUTARS, the Implantcast product, took Dr. Buch almost four months to get FDA approval for use.
6. Dr. Buch took courses and earned certifications in order to familiarize himself with the Implantcast MUTARS line so that he could perform these procedures on FDA-approved cases.
7. An eighth surgery using Implantcast will be taking place on Nov. 21, 2015 at Dallas Medical Center. Dr. Buch will be performing a total knee replacement.
More articles on devices and implants:
St. Jude Medical’s recharge-free SCS system earns FDA approval: 5 notes
K2M, SeaSpine, Blue Belt Technologies & more — 18 key notes
$5M donation to MUSC creates idea incubator; spine device is 1st project: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
